Global Connected Smart Drug Delivery Systems Market

Report ID : 1291 | Published : 2022-07-04 | Pages: | Format: PDF/EXCEL

The Global Connected Smart Drug Delivery Systems market size was accounted at USD 799.3 Mn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 37.4% from 2022 to 2028. Connected Smart Drug Delivery Systems are the devices which perform multiple functions with the highest degree of smartness. Smart drug delivery devices help to reduce the dosage, frequency of the dosage and adverse effects of the drug. These devices are beneficial in the treatment of respiratory diseases, diabetes and other cardiovascular disorders. Connected smart drug delivery systems are more effective and can be self-managed. COVID-19 Pandemic is significantly augmenting the need for such smart (contactless) devices, and hence, in future, there will be a high requirement for such systems, which will ultimately result in Connected Smart Drug Delivery System’s market growth.

Connected smart drug delivery is an attractive industry option with multiple growth opportunities in research and development, technologies, applications, and formulations. Market analysis in terms of the product clearly suggests that the connected sensors segment dominated the market. And the COVID-19 Pandemic is also fueling new developments in the respiratory sector (inhalation devices). Also, recently a Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Spreading awareness regarding the benefits of connected smart systems over conventional systems is expected to enhance the product demand. Fast adoption of new technologies and smart devices, the invention of new products according to patients’ requirements, and the creation of smartphone applications and low-cost connectivity devices will also help grow this market.

The Global Connected Smart Drug Delivery Systems Market is segmented on the basis of products, Therapeutic Area, End user and region. Products market is further categorized into Connected Inhalers, Connected Auto injectors, Connected Needle-Free Injectors, Connected Pen injectors, Connected Insulin Pumps, Connected Wearable Injectors/Patch Pumps, Add-On Sensors. Based on the different disorders market of Therapeutic Area can be subdivided into Metabolic disorders, Neurological disorders, Respiratory disorders and Others. On the basis of End user, market is sub-divided into Hospitals, Clinics, and Homecare.  Based on the region, the market of Connected Smart Drug Delivery Systems has been segmented into North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of forecast period.

The key players of this market include BIOCORP, Elcam Drug Delivery Devices (E3D), Novo Nordisk, Merck, Pneuma Respiratory, H&T Presspart, Nemera, Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Haselmeier Inc., Portal Instruments Inc, West Pharmaceutical Services Inc. , Emperra GmbH E-Health Technologies, Amiko Digital Health Limited, Cognita Labs,DIAMESCO CO., Ltd., Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical) , Enable Injections, Bigfoot Biomedical Inc., Medtronic Plc, Companion Medical , Sorrel Medical, Cohero Health, Inc., Propeller Health, Pendiq Intelligent Diabetes Care, Phillips-Medisize, Becton, Dickinson and Company (BD), Noble International Inc, etectRx, Aterica Inc., Findair Sp. z o. o., Recipharm AB, Aero Pump GmbH, Jiangsu Delfu medical device Co.,Ltd, and other prominent players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Connected Smart Drug Delivery Systems Market Snapshot

Chapter 4. Global Connected Smart Drug Delivery Systems Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2019 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2028 for the following By Products:

5.2.1. Connected Inhalers

5.2.2. Connected Autoinjectors

5.2.3. Connected Needle-Free Injectors

5.2.4. Connected Pen injectors

5.2.5. Connected Insulin Pumps

5.2.6. Connected Wearable Injectors/Patch Pumps

5.2.7. Add-On Sensors

Chapter 6. Connected Smart Drug Delivery Systems Market Segmentation 2: By Applications Estimates & Trend Analysis

6.1. By Therapeutic Area Analysis & Market Share, 2019 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2028 for the following By Therapeutic Area:

6.2.1. Metabolic Disorders

6.2.2. Neurological Disorders

6.2.3. Respiratory Disorders

6.2.4. Others

Chapter 7. Connected Smart Drug Delivery Systems Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By Therapeutic Area Analysis & Market Share, 2019 & 2028

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2028 for the following By End-Users:

7.2.1. Hospital

7.2.2. Clinics

7.2.3. Homecare

Chapter 8. Connected Smart Drug Delivery Systems Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Products, 2019-2028

8.1.2. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Therapeutic Area, 2019-2028

8.1.3. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by End-Users, 2019-2028

8.1.4. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Country, 2019-2028

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2019-2028

8.2.2. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2019-2028

8.2.3. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2019-2028

8.2.4. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2028

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2019-2028

8.3.2. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2019-2028

8.3.3. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2019-2028

8.3.4. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2028

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2019-2028

8.4.2. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2019-2028

8.4.3. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, (US$ Million) 2019-2028

8.4.4. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, (US$ Million) 2019-2028

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2019-2028

8.5.2. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2019-2028

8.5.3. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2019-2028

8.5.4. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) by Country, (US$ Million) 2019-2028

8.5.4.1. South Africa

8.5.4.2. GCC Countries

8.5.4.3. Rest of MEA 

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. BIOCORP

9.2.2. Elcam Drug Delivery Devices (E3D)

9.2.3. Novo Nordisk

9.2.4. Merck

9.2.5. Pneuma Respiratory

9.2.6. H&T Presspart

9.2.7. Nemera

9.2.8. Ypsomed Holdings

9.2.9. Unolife Corporation

9.2.10. Quio Technologies

9.2.11. SHL Group

9.2.12. Haselmeier Inc.

9.2.13. Portal Instruments Inc

9.2.14. West Pharmaceutical Services Inc.

9.2.15. Emperra GmbH E-Health Technologies

9.2.16. Amiko Digital Health Limited

9.2.17. Cognita Labs

9.2.18. DIAMESCO CO., Ltd.|

9.2.19. Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical) 

9.2.20. Enable Injections

9.2.21. Bigfoot Biomedical Inc.

9.2.22. Medtronic Plc

9.2.23. Companion Medical

9.2.25. Cohero Health, Inc.

9.2.26. Propeller Health

9.2.27. Pendiq Intelligent Diabetes Care

9.2.28. Phillips-Medisize

9.2.29. Becton, Dickinson and Company (BD)

9.2.30. Noble International Inc

9.2.31. etectRx

9.2.32. Aterica Inc.

9.2.33. Findair Sp. z o. o.

9.2.34. Recipharm AB

9.2.35. Aero Pump GmbH

9.2.36. Jiangsu Delfu medical device Co.,Ltd

8.3. List of Other Prominent Players

Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 based on Products

  • Connected Inhalers
  • Connected Auto injectors
  • Connected Needle-Free Injectors
  • Connected Pen injectors
  • Connected Insulin Pumps
  • Connected Wearable Injectors/Patch Pumps
  • Add-On Sensors

Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 based on Therapeutic Area

  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Others

Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 based on End-User

  • Hospitals
  • Clinics
  • Homecare

Market Size (Value & Volume) & Forecasts and Trend Analyses, 2019 to 2030 based on region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2030

  • U.S.
  • Canada

Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

Companies Mentioned

  • BIOCORP
  • Elcam Drug Delivery Devices (E3D)
  • Novo Nordisk
  • Merck
  • Pneuma Respiratory
  • H&T Presspart
  • Nemera
  • Ypsomed Holdings
  • Unolife Corporation
  • Quio Technologies
  • SHL Group
  • Haselmeier Inc.
  • Portal Instruments Inc
  • West Pharmaceutical Services Inc.
  • Emperra GmbH E-Health Technologies
  • Amiko Digital Health Limited
  • Cognita Labs
  • DIAMESCO CO., Ltd.|
  • Eitan Medical 
  • Enable Injections
  • Bigfoot Biomedical Inc.
  • Medtronic Plc
  • Companion Medical
  • Cohero Health, Inc.
  • Propeller Health
  • Pendiq Intelligent Diabetes Care
  • Phillips-Medisize
  • Becton, Dickinson and Company (BD)
  • Noble International Inc
  • etectRx
  • Aterica Inc.
  • Findair Sp. z o. o.
  • Recipharm AB
  • Aero Pump GmbH
  • Jiangsu Delfu medical device Co.,Ltd
  • List of Other Prominent Players

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Connected Smart Drug Delivery Systems Market?

USD 799.3 Mn in 2021

growth rate (CAGR) of 37.4% from 2022 to 2028.

Our Clients